OxySure Therapeutics, Inc. - FORM 10-K - EX-23.2 - CONSENT - March 31, 2015

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - OxySure Therapeutics, Inc.Financial_Report.xls
EX-10.29 - EXCLUSIVE DISTRIBUTION AGREEMENT - OxySure Therapeutics, Inc.f10k2014ex10xxix_oxysure.htm
EX-32 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2014ex32_oxysure.htm
EX-31.1 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2014ex31i_oxysure.htm
EX-31.2 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2014ex31ii_oxysure.htm
EX-10.2.3 - SECOND AMENDED AND RESTATED AGREEMENT - OxySure Therapeutics, Inc.f10k2014ex10ii3_oxysure.htm
EX-10.2.4 - SECOND RENEWED AND EXTENDED PROMISSORY NOTE - OxySure Therapeutics, Inc.f10k2014ex10ii4_oxysure.htm
EX-10.26 - SECURITIES PURCHASE AGREEMENT - OxySure Therapeutics, Inc.f10k2014ex10xxvi_oxysure.htm
EX-10.23.1 - AMENDMENT CERTIFICATE OF DESIGNATION - OxySure Therapeutics, Inc.f10k2014ex10xxiii1_oxysure.htm
10-K - ANNUAL REPORT - OxySure Therapeutics, Inc.f10k2014_oxysuresystem.htm
EX-10.27 - FORM OF WARRANT ISSUED TO SECURITIES PURCHASE AGREEMENT - OxySure Therapeutics, Inc.f10k2014ex10xxvii_oxysure.htm

Exhibit 23.2

 

We consent to the inclusion in this Annual Report (Form 10-K) of OxySure Systems, Inc. of our report dated March 31, 2015, with respect to its balance sheet as of December 31, 2014 and 2013, and the related statements of operations, stockholders' equity (deficit), and cash flows for the years then ended to be included in this Annual Report.

 

/s/ Sadler Gibb & Associates, LLC  
Firm’s Manual Signature  
   
Salt Lake City, UT  
City, State  
   
March 31, 2015  
Date  

 

OxySure Therapeutics, Inc. Reports